321 POSTER A phase I trial evaluating pharmacodynamics of deforolimus (AP23573, MK-8669) delivered orally on multiple dosing schedules
L. Berk, D. Miller, D. Clapham, J. Loewy, M. Mita, C. Britten, E. Poplin, C.L. Bedrosian, T. Clackson, V.M. RiveraVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72255-9
File:
PDF, 60 KB
english, 2008